
### [MONDO:0020288](http://purl.obolibrary.org/obo/MONDO_0020288)
**Label:** atrioventricular valve anomaly

**Subclasses:** [MONDO:0020405](http://purl.obolibrary.org/obo/MONDO_0020405) (Straddling and/or overriding mitral valve), [MONDO:0019813](http://purl.obolibrary.org/obo/MONDO_0019813) (congenital tricuspid stenosis), [MONDO:0014344](http://purl.obolibrary.org/obo/MONDO_0014344) (congenital heart defects, multiple types, 4), [MONDO:0020406](http://purl.obolibrary.org/obo/MONDO_0020406) (complete atrioventricular canal-left heart obstruction syndrome), [MONDO:0020407](http://purl.obolibrary.org/obo/MONDO_0020407) (complete atrioventricular canal-ventricle hypoplasia syndrome), [MONDO:0019811](http://purl.obolibrary.org/obo/MONDO_0019811) (tricuspid valve agenesis), [MONDO:0020408](http://purl.obolibrary.org/obo/MONDO_0020408) (complete atrioventricular canal-tetralogy of fallot syndrome), [MONDO:0015275](http://purl.obolibrary.org/obo/MONDO_0015275) (partial atrioventricular canal), [MONDO:0011650](http://purl.obolibrary.org/obo/MONDO_0011650) (atrioventricular septal defect, susceptibility to, 2), [MONDO:0008004](http://purl.obolibrary.org/obo/MONDO_0008004) (familial mitral valve prolapse), [MONDO:0020289](http://purl.obolibrary.org/obo/MONDO_0020289) (congenital tricuspid malformation), [MONDO:0016582](http://purl.obolibrary.org/obo/MONDO_0016582) (congenital mitral malformation), [MONDO:0015273](http://purl.obolibrary.org/obo/MONDO_0015273) (complete atrioventricular canal), [MONDO:0020400](http://purl.obolibrary.org/obo/MONDO_0020400) (congenital supravalvular mitral ring), [MONDO:0020401](http://purl.obolibrary.org/obo/MONDO_0020401) (congenital unguarded mitral orifice), [MONDO:0020402](http://purl.obolibrary.org/obo/MONDO_0020402) (accessory mitral valve tissue), [MONDO:0020403](http://purl.obolibrary.org/obo/MONDO_0020403) (mitral valve agenesis), [MONDO:0020404](http://purl.obolibrary.org/obo/MONDO_0020404) (Shone complex), [MONDO:0011915](http://purl.obolibrary.org/obo/MONDO_0011915) (MMVP2), [MONDO:0007001](http://purl.obolibrary.org/obo/MONDO_0007001) (tricuspid valve prolapse (disease)), [MONDO:0019818](http://purl.obolibrary.org/obo/MONDO_0019818) (cleft mitral valve), [MONDO:0019819](http://purl.obolibrary.org/obo/MONDO_0019819) (double-orifice mitral valve), [MONDO:0019816](http://purl.obolibrary.org/obo/MONDO_0019816) (anomaly of the tricuspid subvalvular apparatus), [MONDO:0019817](http://purl.obolibrary.org/obo/MONDO_0019817) (congenital mitral valve insufficiency and/or stenosis), [MONDO:0019814](http://purl.obolibrary.org/obo/MONDO_0019814) (Straddling or overriding tricuspid valve), [MONDO:0011514](http://purl.obolibrary.org/obo/MONDO_0011514) (tricuspid atresia (disease)), [MONDO:0019815](http://purl.obolibrary.org/obo/MONDO_0019815) (accessory tricuspid valve tissue), [MONDO:0012569](http://purl.obolibrary.org/obo/MONDO_0012569) (MMVP3), [MONDO:0009144](http://purl.obolibrary.org/obo/MONDO_0009144) (Ebstein anomaly), [MONDO:0020397](http://purl.obolibrary.org/obo/MONDO_0020397) (Parachute tricuspid valve), [MONDO:0020398](http://purl.obolibrary.org/obo/MONDO_0020398) (congenital mitral stenosis (disease)), [MONDO:0020399](http://purl.obolibrary.org/obo/MONDO_0020399) (hypoplasia of the mitral valve annulus), [MONDO:0020290](http://purl.obolibrary.org/obo/MONDO_0020290) (atrioventricular septal defect), [MONDO:0010859](http://purl.obolibrary.org/obo/MONDO_0010859) (atrioventricular septal defect 3), [MONDO:0011649](http://purl.obolibrary.org/obo/MONDO_0011649) (AVSD 1), [MONDO:0020396](http://purl.obolibrary.org/obo/MONDO_0020396) (anomaly of the tricuspid valve chordae), [MONDO:0010753](http://purl.obolibrary.org/obo/MONDO_0010753) (cardiac valvular dysplasia, X-linked), [MONDO:0013769](http://purl.obolibrary.org/obo/MONDO_0013769) (atrioventricular septal defect 5), [MONDO:0013747](http://purl.obolibrary.org/obo/MONDO_0013747) (atrioventricular septal defect 4), [MONDO:0015249](http://purl.obolibrary.org/obo/MONDO_0015249) (mitral atresia (disease)), [MONDO:0015989](http://purl.obolibrary.org/obo/MONDO_0015989) (congenital valvular dysplasia), [MONDO:0015109](http://purl.obolibrary.org/obo/MONDO_0015109) (anomaly of the mitral subvalvular apparatus), 

**Mapped go classes:** [GO:0060486](http://purl.obolibrary.org/obo/GO_0060486) (Clara cell differentiation), [GO:0070848](http://purl.obolibrary.org/obo/GO_0070848) (response to growth factor), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0007493](http://purl.obolibrary.org/obo/GO_0007493) (endodermal cell fate determination), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0009956](http://purl.obolibrary.org/obo/GO_0009956) (radial pattern formation), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0110024](http://purl.obolibrary.org/obo/GO_0110024) (positive regulation of cardiac muscle myoblast proliferation), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0060471](http://purl.obolibrary.org/obo/GO_0060471) (cortical granule exocytosis), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0000226](http://purl.obolibrary.org/obo/GO_0000226) (microtubule cytoskeleton organization), [GO:0005243](http://purl.obolibrary.org/obo/GO_0005243) (gap junction channel activity), [GO:0060510](http://purl.obolibrary.org/obo/GO_0060510) (Type II pneumocyte differentiation), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0051891](http://purl.obolibrary.org/obo/GO_0051891) (positive regulation of cardioblast differentiation), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0098868](http://purl.obolibrary.org/obo/GO_0098868) (bone growth), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0055077](http://purl.obolibrary.org/obo/GO_0055077) (gap junction hemi-channel activity), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0051145](http://purl.obolibrary.org/obo/GO_0051145) (smooth muscle cell differentiation), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0022857](http://purl.obolibrary.org/obo/GO_0022857) (transmembrane transporter activity), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0060045](http://purl.obolibrary.org/obo/GO_0060045) (positive regulation of cardiac muscle cell proliferation), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0001103](http://purl.obolibrary.org/obo/GO_0001103) (RNA polymerase II repressing transcription factor binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0060849](http://purl.obolibrary.org/obo/GO_0060849) (regulation of transcription involved in lymphatic endothelial cell fate commitment), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0070121](http://purl.obolibrary.org/obo/GO_0070121) (Kupffer's vesicle development), [GO:0035239](http://purl.obolibrary.org/obo/GO_0035239) (tube morphogenesis), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0014898](http://purl.obolibrary.org/obo/GO_0014898) (cardiac muscle hypertrophy in response to stress), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0060674](http://purl.obolibrary.org/obo/GO_0060674) (placenta blood vessel development), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0022832](http://purl.obolibrary.org/obo/GO_0022832) (voltage-gated channel activity), [GO:0007343](http://purl.obolibrary.org/obo/GO_0007343) (egg activation), [GO:0045736](http://purl.obolibrary.org/obo/GO_0045736) (negative regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0032911](http://purl.obolibrary.org/obo/GO_0032911) (negative regulation of transforming growth factor beta1 production), [GO:0032912](http://purl.obolibrary.org/obo/GO_0032912) (negative regulation of transforming growth factor beta2 production), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0060838](http://purl.obolibrary.org/obo/GO_0060838) (lymphatic endothelial cell fate commitment), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0035987](http://purl.obolibrary.org/obo/GO_0035987) (endodermal cell differentiation), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction), [GO:0005922](http://purl.obolibrary.org/obo/GO_0005922) (connexin complex), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0060852](http://purl.obolibrary.org/obo/GO_0060852) (regulation of transcription involved in venous endothelial cell fate commitment), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), 

**Class expressions from DL-Learner:**

- Thing 54.66%
- [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration) 50.94%
- [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration) 50.94%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 47.92%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003783](http://purl.obolibrary.org/obo/GO_0003783) (obsolete barbed-end actin capping activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003782](http://purl.obolibrary.org/obo/GO_0003782) (obsolete F-actin capping activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003781](http://purl.obolibrary.org/obo/GO_0003781) (obsolete actin bundling activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003780](http://purl.obolibrary.org/obo/GO_0003780) (obsolete actin cross-linking activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003778](http://purl.obolibrary.org/obo/GO_0003778) (obsolete dynactin motor) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003776](http://purl.obolibrary.org/obo/GO_0003776) (obsolete muscle motor activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003775](http://purl.obolibrary.org/obo/GO_0003775) (obsolete axonemal motor activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003773](http://purl.obolibrary.org/obo/GO_0003773) (obsolete heat shock protein activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003772](http://purl.obolibrary.org/obo/GO_0003772) (obsolete co-chaperonin activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003771](http://purl.obolibrary.org/obo/GO_0003771) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 42.71%


